Atlas Trials

To Evaluate the Safety and Metabolic Profile of Vyvanse for the Treatment of ADHD in Euthymic Adults With Bipolar I/II Disorder

Clinical trial NCT01263548 · COMPLETED

Trial details

NCT number
NCT01263548
Sponsor
University Health Network, Toronto
Status
COMPLETED
Study type
OBSERVATIONAL
Attention Deficit/Hyperactivity DisorderBipolar Disorder
Start date
2010-10-01
Primary completion
2012-01-01
Enrollment
45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.